Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Catalano

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|October 11, 2016
Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experienceLinda P Cho, Matthias Manuel, Paul Catalano, et al.
Scientific Reports|November 9, 2022
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasisDebra Van Egeren, Khushi Kohli, Jeremy L Warner, et al.
Diseases of the Colon and Rectum|March 11, 2014
Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resectionSagar A Patel, Yu-Hui Chen, Jason L Hornick, et al.
The Oncologist|June 23, 2019
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)Michael K Gibson, Paul Catalano, Lawrence R Kleinberg, et al.
Practical Radiation Oncology|June 18, 2022
ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRTNicholas Damico, Joshua Meyer, Prajnan Das, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Radiology|December 1, 2020
Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell CarcinomaLeo L Tsai, Rupal S Bhatt, Meaghan F Strob, et al.
The Oncologist|April 27, 2023
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN TrialShannon Stockton, Paul Catalano, Steven J Cohen, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 12, 2020
Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective studyGrace Lee, Luke Besse, Nayan Lamba, et al.
Journal of Geriatric Oncology|March 24, 2023
The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patientsEfrat Dotan, Paul Catalano, Leon Lenchik, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|October 11, 2016
Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experienceLinda P Cho, Matthias Manuel, Paul Catalano, et al.
Scientific Reports|November 9, 2022
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasisDebra Van Egeren, Khushi Kohli, Jeremy L Warner, et al.
Diseases of the Colon and Rectum|March 11, 2014
Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resectionSagar A Patel, Yu-Hui Chen, Jason L Hornick, et al.
The Oncologist|June 23, 2019
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)Michael K Gibson, Paul Catalano, Lawrence R Kleinberg, et al.
Practical Radiation Oncology|June 18, 2022
ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRTNicholas Damico, Joshua Meyer, Prajnan Das, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Radiology|December 1, 2020
Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell CarcinomaLeo L Tsai, Rupal S Bhatt, Meaghan F Strob, et al.
The Oncologist|April 27, 2023
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN TrialShannon Stockton, Paul Catalano, Steven J Cohen, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 12, 2020
Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective studyGrace Lee, Luke Besse, Nayan Lamba, et al.
Journal of Geriatric Oncology|March 24, 2023
The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patientsEfrat Dotan, Paul Catalano, Leon Lenchik, et al.
Pageof 6